Abstract
Experiences with childhood hemolytic uremic syndrome (HUS) in Canada will focus on the development of the Canadian Pediatric Kidney Disease Research Centre (CPKDRC) and the results of our collaborative research over a 13-year period (1985-1998).
MeSH terms
-
Adolescent
-
Age of Onset
-
Canada / epidemiology
-
Child
-
Child, Preschool
-
Databases as Topic
-
Escherichia coli Infections / epidemiology*
-
Escherichia coli Infections / microbiology*
-
Escherichia coli O157 / metabolism
-
Escherichia coli O157 / pathogenicity*
-
Hemolytic-Uremic Syndrome / epidemiology*
-
Hemolytic-Uremic Syndrome / microbiology*
-
Hemolytic-Uremic Syndrome / prevention & control
-
Humans
-
Kidney Failure, Chronic / microbiology
-
Organosilicon Compounds / therapeutic use
-
Program Development
-
Renal Dialysis
-
Risk Factors
-
Shiga Toxins / metabolism
-
Treatment Outcome
-
Trisaccharides / therapeutic use
Substances
-
Organosilicon Compounds
-
SYNSORB Pk
-
Shiga Toxins
-
Trisaccharides